Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $2,148 | 5 | 92.2% |
| Food and Beverage | $181.99 | 2 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $2,148 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $139.37 | 1 | $0 (2024) |
| PFIZER INC. | $42.62 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.37 | 1 | Novartis Pharmaceuticals Corporation ($139.37) |
| 2023 | $1,510 | 2 | AbbVie Inc. ($1,510) |
| 2022 | $637.50 | 3 | ABBVIE INC. ($637.50) |
| 2018 | $42.62 | 1 | PFIZER INC. ($42.62) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $139.37 | General |
| Category: Dermatology | ||||||
| 03/07/2023 | AbbVie Inc. | RINVOQ (Biological) | Grant | Cash or cash equivalent | $755.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Grant | Cash or cash equivalent | $755.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2022 | ABBVIE INC. | SKYRIZI (Biological) | Grant | Cash or cash equivalent | $382.50 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Grant | Cash or cash equivalent | $204.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Grant | Cash or cash equivalent | $51.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $42.62 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,257 | 1,982 | $492,149 | $49,247 |
| 2022 | 13 | 981 | 1,596 | $339,191 | $37,700 |
| 2021 | 13 | 1,169 | 2,035 | $403,280 | $47,689 |
| 2020 | 13 | 831 | 1,280 | $270,347 | $28,712 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 354 | $77,278 | $13,680 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 190 | $59,774 | $11,370 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 210 | 251 | $74,296 | $7,063 | 9.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 75 | 82 | $30,570 | $3,180 | 10.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $26,775 | $2,669 | 10.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 121 | 133 | $70,091 | $2,175 | 3.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $12,135 | $1,877 | 15.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $15,521 | $1,507 | 9.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $22,242 | $1,449 | 6.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 156 | 716 | $45,824 | $949.98 | 2.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 30 | 31 | $20,522 | $837.37 | 4.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 49 | $13,916 | $687.25 | 4.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $7,056 | $644.60 | 9.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $3,572 | $554.82 | 15.5% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $7,095 | $258.60 | 3.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 19 | $4,494 | $254.61 | 5.7% |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t | Office | 2023 | 15 | 17 | $989.40 | $89.44 | 9.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 285 | $58,140 | $11,894 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 171 | $50,274 | $9,735 | 19.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 168 | 201 | $55,677 | $5,843 | 10.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 66 | 70 | $24,500 | $3,091 | 12.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $11,988 | $1,933 | 16.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 81 | 89 | $46,903 | $1,560 | 3.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 34 | 55 | $15,620 | $835.89 | 5.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 120 | 607 | $38,848 | $815.19 | 2.1% |
About Dr. Apple Bodemer, MD
Dr. Apple Bodemer, MD is a Dermatology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770546426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Apple Bodemer, MD has received a total of $2,329 in payments from pharmaceutical and medical device companies, with $139.37 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Grant" ($2,148).
As a Medicare-enrolled provider, Bodemer has provided services to 4,238 Medicare beneficiaries, totaling 6,893 services with total Medicare billing of $163,349. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Madison, WI
- Active Since 04/11/2006
- Last Updated 01/22/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1770546426
Products in Payments
- SKYRIZI (Biological) $1,393
- RINVOQ (Biological) $755.00
- COSENTYX (Drug) $139.37
- EUCRISA (Drug) $42.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Madison
Dr. Jeremy Moss, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $2.5M
Molly Hinshaw, Md, MD
Dermatology — Payments: $241,363
Michael Christopher, M.d, M.D
Dermatology — Payments: $7,743
Dr. Stefan Schieke, M.d, M.D
Dermatology — Payments: $6,859
Dr. Harry Sharata, Md, Ph.d, MD, PH.D
Dermatology — Payments: $5,309
Dr. Joseph Dai, M.d, M.D
Dermatology — Payments: $4,865